These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32204650)

  • 1. Cannabis Use as Determined by Biologic Testing in Maternal and Newborn Urines during a Period of Drug Liberalization.
    Mark K; Khan A; Terplan M
    Subst Use Misuse; 2020; 55(8):1343-1346. PubMed ID: 32204650
    [No Abstract]   [Full Text] [Related]  

  • 2. Cannabis Use Based on Urine Drug Screens in Pregnancy and Its Association With Infant Birth Weight.
    Howard DS; Dhanraj DN; Devaiah CG; Lambers DS
    J Addict Med; 2019; 13(6):436-441. PubMed ID: 30908346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study.
    ElSohly MA; deWit H; Wachtel SR; Feng S; Murphy TP
    J Anal Toxicol; 2001 Oct; 25(7):565-71. PubMed ID: 11599601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance use in rural Midwestern pregnant women.
    Yawn BP; Yawn RA; Uden DL
    Arch Fam Med; 1992 Sep; 1(1):83-8. PubMed ID: 1341592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence.
    Schuster RM; Potter K; Vandrey R; Hareli M; Gilman J; Schoenfeld D; Evins AE
    J Psychopharmacol; 2020 Feb; 34(2):197-210. PubMed ID: 31535597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short communication: Urinary excretion of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol in a pregnant woman following heavy, chronic cannabis use.
    Westin AA; Huestis MA; Aarstad K; Spigset O
    J Anal Toxicol; 2009; 33(9):610-4. PubMed ID: 20040136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance use in pregnancy.
    Wong S; Ordean A; Kahan M; ; ; ; ;
    J Obstet Gynaecol Can; 2011 Apr; 33(4):367-384. PubMed ID: 21501542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Historical and clinical factors associated with positive urine toxicology screening on labor and delivery.
    Son SL; Guiahi M; Heyborne KD
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():261-266. PubMed ID: 30041147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis and pregnancy: Maternal child health implications during a period of drug policy liberalization.
    Mark K; Terplan M
    Prev Med; 2017 Nov; 104():46-49. PubMed ID: 28528172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Positive" urine testing for Cannabis is associated with increased risk of traffic crashes.
    Del Balzo G; Gottardo R; Mengozzi S; Dorizzi RM; Bortolotti F; Appolonova S; Tagliaro F
    J Pharm Biomed Anal; 2018 Mar; 151():71-74. PubMed ID: 29310049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance between verbal report and urine screen of recent marijuana use in adolescents.
    Akinci IH; Tarter RE; Kirisci L
    Addict Behav; 2001; 26(4):613-9. PubMed ID: 11456081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and associated birth outcomes of co-use of Cannabis and tobacco cigarettes during pregnancy.
    Coleman-Cowger VH; Oga EA; Peters EN; Mark K
    Neurotoxicol Teratol; 2018; 68():84-90. PubMed ID: 29883744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marijuana-positive urine test results from consumption of hemp seeds in food products.
    Fortner N; Fogerson R; Lindman D; Iversen T; Armbruster D
    J Anal Toxicol; 1997 Oct; 21(6):476-81. PubMed ID: 9323528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal drug use in Minneapolis-St Paul, Minn. A 4-year trend.
    Yawn BP; Thompson LR; Lupo VR; Googins MK; Yawn RA
    Arch Fam Med; 1994 Jun; 3(6):520-7. PubMed ID: 8081532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited Utility of Toxicology Testing at Delivery for Perinatal Cannabis Use.
    Sarathy L; Chou JH; Lerou PH; Terplan M; Mark K; Dorfman S; Wilens TE; Bernstein SN; Schiff DM
    Hosp Pediatr; 2023 Apr; 13(4):317-325. PubMed ID: 36855896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Birth outcomes associated with cannabis use before and during pregnancy.
    Hayatbakhsh MR; Flenady VJ; Gibbons KS; Kingsbury AM; Hurrion E; Mamun AA; Najman JM
    Pediatr Res; 2012 Feb; 71(2):215-9. PubMed ID: 22258135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening, testing, and reporting for drug and alcohol use on labor and delivery: a survey of Maryland birthing hospitals.
    Miller C; Lanham A; Welsh C; Ramanadhan S; Terplan M
    Soc Work Health Care; 2014; 53(7):659-69. PubMed ID: 25133299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of Mathematical Models to Predict New Cannabis Use by Urine Drug Testing: It Is Time to Move Forward.
    Breindahl T; Kimergård A; Leutscher PDC; Hindersson P
    J Anal Toxicol; 2021 Jul; 45(6):e15-e19. PubMed ID: 33876828
    [No Abstract]   [Full Text] [Related]  

  • 19. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
    Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
    J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the impact of hemp food consumption on workplace drug tests.
    Leson G; Pless P; Grotenhermen F; Kalant H; ElSohly MA
    J Anal Toxicol; 2001; 25(8):691-8. PubMed ID: 11765026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.